{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:39:37Z","timestamp":1795041577762,"version":"4.10.2"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI131453"],"award-info":[{"award-number":["U19 AI131453"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U01 681 AI136779"],"award-info":[{"award-number":["U01 681 AI136779"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007408","name":"Pitt | Medical Center, University of Pittsburgh","doi-asserted-by":"publisher","award":["88906"],"award-info":[{"award-number":["88906"]}],"id":[{"id":"10.13039\/100007408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI089443"],"award-info":[{"award-number":["AI089443"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI74490"],"award-info":[{"award-number":["AI74490"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-71280-8","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:04:28Z","timestamp":1776416668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Donor-derived regulatory dendritic cell infusion and early immunosuppressive drug withdrawal in living-donor liver transplantation: a phase I\/IIa trial"],"prefix":"10.1038","volume":"17","author":[{"given":"Abhinav","family":"Humar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6723-4299","authenticated-orcid":false,"given":"Yannis","family":"Hadjiyannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian M.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth D.","family":"Elinoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaytha R.","family":"Ganesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan F.","family":"Zahorchak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8617-6768","authenticated-orcid":false,"given":"Erin M.","family":"Ables","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindi A.","family":"Styn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Landsittel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Zeevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi G.","family":"Lakkis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Metes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6731-8871","authenticated-orcid":false,"given":"Angus W.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"71280_CR1","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/lt.21803","volume":"15","author":"S Karie-Guigues","year":"2009","unstructured":"Karie-Guigues, S. et al. Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study. Liver Transpl. 15, 1083\u20131091 (2009).","journal-title":"Liver Transpl."},{"key":"71280_CR2","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/lt.21821","volume":"15","author":"P Sharma","year":"2009","unstructured":"Sharma, P. et al. Renal outcomes after liver transplantation in the model for end-stage liver disease era. Liver Transpl. 15, 1142\u20131148 (2009).","journal-title":"Liver Transpl."},{"key":"71280_CR3","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/hep.26426","volume":"58","author":"C Ben\u00edtez","year":"2013","unstructured":"Ben\u00edtez, C. et al. Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology 58, 1824\u20131835 (2013).","journal-title":"Hepatology"},{"key":"71280_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1001\/jama.2011.2014","volume":"307","author":"S Feng","year":"2012","unstructured":"Feng, S. et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. Jama 307, 283\u2013293 (2012).","journal-title":"Jama"},{"key":"71280_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.humimm.2017.10.007","volume":"79","author":"J Levitsky","year":"2018","unstructured":"Levitsky, J. & Feng, S. Tolerance in clinical liver transplantation. Hum. Immunol. 79, 283\u2013287 (2018).","journal-title":"Hum. Immunol."},{"key":"71280_CR6","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41575-020-0334-4","volume":"17","author":"AW Thomson","year":"2020","unstructured":"Thomson, A. W., Vionnet, J. & Sanchez-Fueyo, A. Understanding, predicting and achieving liver transplant tolerance: from bench to bedside. Nat. Rev. Gastroenterol. Hepatol. 17, 719\u2013739 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"71280_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330\u2013336 (2003).","journal-title":"Nat. Immunol."},{"key":"71280_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1084\/jem.20082394","volume":"206","author":"C Ohnmacht","year":"2009","unstructured":"Ohnmacht, C. et al. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 206, 549\u2013559 (2009).","journal-title":"J. Exp. Med."},{"key":"71280_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/00002281-200307000-00010","volume":"15","author":"E Gambineri","year":"2003","unstructured":"Gambineri, E., Torgerson, T. R. & Ochs, H. D. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. 15, 430\u2013435 (2003).","journal-title":"Curr. Opin. Rheumatol."},{"key":"71280_CR10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nri2132","volume":"7","author":"AE Morelli","year":"2007","unstructured":"Morelli, A. E. & Thomson, A. W. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7, 610\u2013621 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"71280_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nri3227","volume":"12","author":"KJ Wood","year":"2012","unstructured":"Wood, K. J., Bushell, A. & Hester, J. Regulatory immune cells in transplantation. Nat. Rev. Immunol. 12, 417\u2013430 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"71280_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nm1688","volume":"14","author":"O Joffre","year":"2008","unstructured":"Joffre, O. et al. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat. Med. 14, 88\u201392 (2008).","journal-title":"Nat. Med."},{"key":"71280_CR13","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/ajt.15700","volume":"20","author":"A S\u00e1nchez-Fueyo","year":"2020","unstructured":"S\u00e1nchez-Fueyo, A. et al. Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation. Am. J. Transpl. 20, 1125\u20131136 (2020).","journal-title":"Am. J. Transpl."},{"key":"71280_CR14","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","volume":"395","author":"B Sawitzki","year":"2020","unstructured":"Sawitzki, B. et al. Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials. Lancet 395, 1627\u20131639 (2020).","journal-title":"Lancet"},{"key":"71280_CR15","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/ajt.16395","volume":"21","author":"PN Harden","year":"2021","unstructured":"Harden, P. N. et al. Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients. Am. J. Transpl. 21, 1603\u20131611 (2021).","journal-title":"Am. J. Transpl."},{"key":"71280_CR16","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1111\/ajt.14415","volume":"17","author":"S Chandran","year":"2017","unstructured":"Chandran, S. et al. Polyclonal regulatory T cell therapy for control of inflammation in kidney transplants. Am. J. Transpl. 17, 2945\u20132954 (2017).","journal-title":"Am. J. Transpl."},{"key":"71280_CR17","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.4049\/jimmunol.1100762","volume":"187","author":"JA Hutchinson","year":"2011","unstructured":"Hutchinson, J. A. et al. Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J. Immunol. 187, 2072\u20132078 (2011).","journal-title":"J. Immunol."},{"key":"71280_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.kint.2022.08.037","volume":"103","author":"A Moreau","year":"2023","unstructured":"Moreau, A. et al. A Phase I\/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients. Kidney Int. 103, 627\u2013637 (2023).","journal-title":"Kidney Int"},{"key":"71280_CR19","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","volume":"21","author":"RM Steinman","year":"2003","unstructured":"Steinman, R. M., Hawiger, D. & Nussenzweig, M. C. Tolerogenic dendritic cells. Annu Rev. Immunol. 21, 685\u2013711 (2003).","journal-title":"Annu Rev. Immunol."},{"key":"71280_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/B978-0-12-380995-7.00004-5","volume":"108","author":"RA Maldonado","year":"2010","unstructured":"Maldonado, R. A. & von Andrian, U. H. How tolerogenic dendritic cells induce regulatory T cells. Adv. Immunol. 108, 111\u2013165 (2010).","journal-title":"Adv. Immunol."},{"key":"71280_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/tri.13504","volume":"33","author":"J Ochando","year":"2020","unstructured":"Ochando, J., Ordikhani, F., Jordan, S., Boros, P. & Thomson, A. W. Tolerogenic dendritic cells in organ transplantation. Transpl. Int. 33, 113\u2013127 (2020).","journal-title":"Transpl. Int."},{"key":"71280_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/MOT.0000000000001127","volume":"29","author":"Y Hadjiyannis","year":"2024","unstructured":"Hadjiyannis, Y. & Thomson, A. W. Regulatory dendritic cell therapy in organ transplantation. Curr. Opin. Organ Transpl. 29, 121\u2013130 (2024).","journal-title":"Curr. Opin. Organ Transpl."},{"key":"71280_CR23","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/tri.12889","volume":"30","author":"A Moreau","year":"2017","unstructured":"Moreau, A., Alliot-Licht, B., Cuturi, M. C. & Blancho, G. Tolerogenic dendritic cell therapy in organ transplantation. Transpl. Int. 30, 754\u2013764 (2017).","journal-title":"Transpl. Int."},{"key":"71280_CR24","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1182\/blood-2009-10-251058","volume":"116","author":"SJ Divito","year":"2010","unstructured":"Divito, S. J. et al. Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation. Blood 116, 2694\u20132705 (2010).","journal-title":"Blood"},{"key":"71280_CR25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/MOT.0000000000000097","volume":"19","author":"AE Morelli","year":"2014","unstructured":"Morelli, A. E. & Thomson, A. W. Orchestration of transplantation tolerance by regulatory dendritic cell therapy or in-situ targeting of dendritic cells. Curr. Opin. Organ Transpl. 19, 348\u2013356 (2014).","journal-title":"Curr. Opin. Organ Transpl."},{"key":"71280_CR26","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/j.1600-6143.2012.04060.x","volume":"12","author":"Z Wang","year":"2012","unstructured":"Wang, Z. et al. Dendritic cell therapies in transplantation revisited: deletion of recipient DCs deters the effect of therapeutic DCs. Am. J. Transpl. 12, 1398\u20131408 (2012).","journal-title":"Am. J. Transpl."},{"key":"71280_CR27","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1002\/eji.200940085","volume":"40","author":"M Nasreen","year":"2010","unstructured":"Nasreen, M., Waldie, T. M., Dixon, C. M. & Steptoe, R. J. Steady-state antigen-expressing dendritic cells terminate CD4+ memory T-cell responses. Eur. J. Immunol. 40, 2016\u20132025 (2010).","journal-title":"Eur. J. Immunol."},{"key":"71280_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1189\/jlb.1107744","volume":"84","author":"AE Anderson","year":"2008","unstructured":"Anderson, A. E. et al. Differential regulation of na\u00efve and memory CD4+ T cells by alternatively activated dendritic cells. J. Leukoc. Biol. 84, 124\u2013133 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"71280_CR29","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4049\/jimmunol.0900032","volume":"184","author":"TJ Kenna","year":"2010","unstructured":"Kenna, T. J. et al. Targeting antigen to diverse APCs inactivates memory CD8+ T cells without eliciting tissue-destructive effector function. J. Immunol. 184, 598\u2013606 (2010).","journal-title":"J. Immunol."},{"key":"71280_CR30","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/j.1600-6143.2004.00453.x","volume":"4","author":"AW Bingaman","year":"2004","unstructured":"Bingaman, A. W. & Farber, D. L. Memory T cells in transplantation: generation, function, and potential role in rejection. Am. J. Transpl. 4, 846\u2013852 (2004).","journal-title":"Am. J. Transpl."},{"key":"71280_CR31","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1097\/01.ASN.0000085020.78117.70","volume":"14","author":"FG Lakkis","year":"2003","unstructured":"Lakkis, F. G. & Sayegh, M. H. Memory T cells: a hurdle to immunologic tolerance. J. Am. Soc. Nephrol. 14, 2402\u20132410 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"71280_CR32","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1600-6143.2005.01215.x","volume":"6","author":"A Valujskikh","year":"2006","unstructured":"Valujskikh, A. The challenge of inhibiting alloreactive T-cell memory. Am. J. Transpl. 6, 647\u2013651 (2006).","journal-title":"Am. J. Transpl."},{"key":"71280_CR33","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/ajt.12310","volume":"13","author":"MB Ezzelarab","year":"2013","unstructured":"Ezzelarab, M. B. et al. Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates. Am. J. Transpl. 13, 1989\u20132005 (2013).","journal-title":"Am. J. Transpl."},{"key":"71280_CR34","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1111\/ajt.15205","volume":"19","author":"A Shaked","year":"2019","unstructured":"Shaked, A. et al. Outcomes of immunosuppression minimization and withdrawal early after liver transplantation. Am. J. Transpl. 19, 1397\u20131409 (2019).","journal-title":"Am. J. Transpl."},{"key":"71280_CR35","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.ajt.2024.10.022","volume":"25","author":"N Tanimine","year":"2025","unstructured":"Tanimine, N. et al. Donor-specific immune senescence as a candidate biomarker of operational tolerance following liver transplantation in adults: Results of a prospective, multicenter cohort study. Am. J. Transpl. 25, 1030\u20131044 (2025).","journal-title":"Am. J. Transpl."},{"key":"71280_CR36","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1111\/ajt.16393","volume":"21","author":"C Macedo","year":"2021","unstructured":"Macedo, C. et al. Donor-derived regulatory dendritic cell infusion results in host cell cross-dressing and T cell subset changes in prospective living donor liver transplant recipients. Am. J. Transpl. 21, 2372\u20132386 (2021).","journal-title":"Am. J. Transpl."},{"key":"71280_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf4287","volume":"15","author":"LM Tran","year":"2023","unstructured":"Tran, L. M. et al. Donor-derived regulatory dendritic cell infusion modulates effector CD8(+) T cell and NK cell responses after liver transplantation. Sci. Transl. Med. 15, eadf4287 (2023).","journal-title":"Sci. Transl. Med"},{"key":"71280_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2025.111312","volume":"86","author":"H Corello","year":"2025","unstructured":"Corello, H., Gimferrer, I., Perkins, J., Kling, C. E. & Henderson, M. Positive crossmatch with persistent donor specific antibodies increases risk of rejection in liver transplantation: A retrospective single-center analysis. Hum. Immunol. 86, 111312 (2025).","journal-title":"Hum. Immunol."},{"key":"71280_CR39","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jcyt.2022.11.005","volume":"25","author":"AF Zahorchak","year":"2023","unstructured":"Zahorchak, A. F. et al. Manufacturing and validation of Good Manufacturing Practice-compliant regulatory dendritic cells for infusion into organ transplant recipients. Cytotherapy 25, 432\u2013441 (2023).","journal-title":"Cytotherapy"},{"key":"71280_CR40","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1111\/ajt.13909","volume":"16","author":"AJ Demetris","year":"2016","unstructured":"Demetris, A. J. et al. 2016 comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection. Am. J. Transpl. 16, 2816\u20132835 (2016).","journal-title":"Am. J. Transpl."},{"key":"71280_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo2628","volume":"14","author":"Q Tang","year":"2022","unstructured":"Tang, Q. et al. Selective decrease of donor-reactive T(regs) after liver transplantation limits T(reg) therapy for promoting allograft tolerance in humans. Sci. Transl. Med. 14, eabo2628 (2022).","journal-title":"Sci. Transl. Med."},{"key":"71280_CR42","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/hep.28459","volume":"64","author":"S Todo","year":"2016","unstructured":"Todo, S. et al. A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation. Hepatology 64, 632\u2013643 (2016).","journal-title":"Hepatology"},{"key":"71280_CR43","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1002\/hep.29529","volume":"67","author":"Y Ono","year":"2018","unstructured":"Ono, Y. et al. Graft-infiltrating PD-L1(hi) cross-dressed dendritic cells regulate antidonor T cell responses in mouse liver transplant tolerance. Hepatology 67, 1499\u20131515 (2018).","journal-title":"Hepatology"},{"key":"71280_CR44","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cgh.2016.07.035","volume":"15","author":"J Levitsky","year":"2017","unstructured":"Levitsky, J. et al. Acute rejection increases risk of graft failure and death in recent liver transplant recipients. Clin. Gastroenterol. Hepatol. 15, 584\u2013593.e582 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"71280_CR45","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/TP.0000000000004288","volume":"107","author":"RA Sosa","year":"2023","unstructured":"Sosa, R. A. et al. Apheresis of deceased donors as a new source of mobilized peripheral blood hematopoietic stem cells for transplant tolerance. Transplantation 107, 504\u2013510 (2023).","journal-title":"Transplantation"},{"key":"71280_CR46","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1001\/jama.2019.3087","volume":"321","author":"E Juszczak","year":"2019","unstructured":"Juszczak, E., Altman, D. G., Hopewell, S. & Schulz, K. Reporting of multi-arm parallel-group randomized trials: extension of the CONSORT 2010 statement. JAMA 321, 1610\u20131620 (2019).","journal-title":"JAMA"},{"key":"71280_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/TP.0b013e31821cdf0d","volume":"92","author":"G H\u00f6nger","year":"2011","unstructured":"H\u00f6nger, G. et al. Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection. Transplantation 92, 41\u201347 (2011).","journal-title":"Transplantation"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71280-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71280-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71280-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:04:30Z","timestamp":1776416670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71280-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["71280"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-71280-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.H., F.G.L., D.M.M., and A.W.T. are co-inventors of University of Pittsburgh invention disclosures that concern protocols for clinical testing of regulatory DCs in human organ transplantation. A.F.Z., F.G.L., and A.W.T. are co-inventors of University of Pittsburgh invention disclosures and a provisional patent application for generation of human regulatory DCs for application in human organ transplantation. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3226"}}